Insurers Should Prevent Pharmacy Counter Sticker Shock, Not Encourage It
BIOtech Now Trevor Roberts Sticker shock at the pharmacy counter is becoming increasingly more common for patients across the nation. But with […]
Category: News
Insurers and PBMs Limit Access to Safer Opioid Alternatives
BIOtech Now Andrew Segerman Opioid abuse and addiction in America continues to ravish communities, families, and individuals across the nation. With an […]
Debunking a Common Myth on Out-of-Pocket Costs
BIOtech Now Jim Greenwood The facts continue to show that, when it comes to prescription drug costs, the country is heading in […]
Four Questions for the Energy and Commerce Hearing on 340B
BIOtech Now Daniel Seaton Later this morning, the House Energy and Commerce Committee will hold a hearing to examine the rampant abuse […]
FDA Protects Patients While Promoting Innovation
BIOtech Now Daniel Seaton Today, 83 percent of children with cancer survive, compared to just 58 percent in the mid-1970s. Hepatitis C, […]
I-MAK’s Distorted View of the U.S. Patent System
BIOtech Now Tom DiLenge In an opinion piece published at CNBC.com, Tahir Amin — co-founder of I-MAK — blames the U.S. patent […]
Co-Pay Accumulator Programs Are a Bad Deal for Patients
BIOtech Now Andrew Segerman As we see time and time again, health insurance providers and pharmacy benefit managers (PBMs) are beginning to […]
House Passes SUPPORT for Patients and Communities Act to Combat America’s Opioid Crisis
BIOtech Now Andrew Segerman Opioid abuse and addiction in America has reached epidemic heights. As a nation, we’re spending more than $500 […]
New Report Offers “Distorted View” of Biopharma Industry
BIOtech Now Brian Newell This week, the Minority Staff of the U.S. Senate Committee on Finance released a report entitled, “A Tangled […]
Insurers Shift Costs and Facts
BIOtech Now Andrew Segerman As health insurance companies begin setting rates for 2019, many consumers are once again faced with skyrocketing premium […]
Future Leaders in Biotechnology
BIOtech Now Andrew Segerman BIO’s International Convention was packed with compelling keynote speeches, and dozens of fireside chats and breakout sessions featuring […]
Heralding In A New Era of Precision Medicine
BIOtech Now Jeremy Isenberg The healthcare ecosystem is experiencing an acceleration in the uptake of the precision medicine paradigm due to many […]
Ending the Opioid Epidemic Through Innovation
BIOtech Now Brian Newell Every day the opioid epidemic is destroying lives and communities across the country. Dr. Jeremy Levin, chairman and […]
Robin Roberts Shares the Journey
BIOtech Now Athena Staton When Good Morning America co-anchor Robin Roberts was diagnosed with cancer in 2007, she took her mother’s advice […]
NORD and the Orphan Drug Act Celebrate 35 Years Driving Rare Disease Advocacy, Research, and Innovation
BIOtech Now BIOtechNOW Editor The National Organization for Rare Disorders (NORD) has been instrumental in influencing public policy, regulatory frameworks, research, and […]
Newborn Screening – How to Fill the Gap to End Diagnostic Odysseys
BIOtech Now BIOtechNOW Editor Many of the over 7000 rare diseases identified so far are not obvious at birth or may come […]
On the President’s Drug Cost Plan, Three Important Concerns
BIOtech Now Dan Durham Part 1. Restricting access under Medicare Part D The Trump administration is out with its plan to lower […]
Drug Importation and Its Dangerous Side Effects
BIOtech Now Andrew Segerman Writing for the National Review, Sally Pipes of the Pacific Research Institute authors a stark warning about the […]
BIO Communications Responds to Misleading Op-Ed about Medicaid Drug Costs
BIOtech Now Andrew Segerman This week, Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center authored an op-ed about the cost of prescription […]
Dr. Jeremy Levin on BIO’s Path to an Addiction-Free America
BIOtech Now Andrew Segerman This week, Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics and Chair of BIO’s Opioid Working Group […]